Načítá se...
Differential Modulation of Farnesoid X Receptor Signaling Pathway by the Thiazolidinediones
Thiazolidinediones (TZD), including troglitazone, rosiglitazone, and pioglitazone, are agonists of peroxisome proliferator-activated receptor (PPAR)-γ and belong to a class of insulin-sensitizing drugs for type 2 diabetes mellitus. However, member-specific, PPARγ-independent activities and toxicity...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society for Pharmacology and Experimental Therapeutics
2009
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2700164/ https://ncbi.nlm.nih.gov/pubmed/19369578 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.109.151233 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|